Clinical Trial: Role of Radiotherapy in T1-T2N0M0 Glottic Carcinoma With Poor Differentiation

U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07781098) titled 'Role of Radiotherapy in T1-T2N0M0 Glottic Carcinoma With Poor Differentiation' on Aug. 18.

Brief Summary: There remains no uniform treatment modality for glottic laryngeal carcinoma. Current clinical guidelines broadly recommend surgery or radiotherapy as single-modality treatment for early-stage glottic laryngeal carcinoma. Surgery is the predominant treatment modality for patients with early-stage glottic carcinoma in China. Patients with poorly-differentiated early-stage glottic carcinoma exhibit inferior local control after surgery compared with those with moderately-to-well-differentiated tumours. Data from our previous retrosp...